LAG3 Marks Activated but Hyporesponsive NK Cells

Area of Science:

• Immunology
• Cell Biology
• Cancer Research

Background:

• Natural killer (NK) cells are crucial for immune surveillance but can become dysfunctional under chronic stimulation from cancer or viral infections.
• This NK cell dysfunction mirrors T cell exhaustion, a state less understood in NK cells, hindering therapeutic development.
• Immune checkpoint proteins (ICPs) are upregulated on dysfunctional T cells, and ICP-blocking therapies show promise in cancer treatment.

Purpose of the Study:

• To investigate the conditions leading to the expression of the immune checkpoint protein Lymphocyte-activation gene 3 (LAG3) on NK cells.
• To characterize the phenotype and functional state of LAG3-expressing NK cells.

Main Methods:

• Utilized various experimental models to study NK cell activation and LAG3 expression.
• Analyzed the phenotype, proliferation, and responsiveness of LAG3+ NK cells.
• Compared the transcriptional signature of LAG3+ NK cells to exhausted CD8+ T cells.

Main Results:

• LAG3 is expressed on murine NK cells following activation in contexts including cancer and viral infections.
• LAG3 marks a subset of activated, proliferating NK cells that exhibit reduced responsiveness to stimuli.
• LAG3+ NK cells share transcriptional similarities with exhausted CD8+ T cells.

Conclusions:

• LAG3 is a reliable marker for identifying dysfunctional NK cells in both chronic and acute inflammatory settings.
• Findings support LAG3 as a potential therapeutic target for enhancing NK cell function in diseases like cancer.